drugset / Trial / NCT04667598

Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction

NCT04667598 ↗

Phase 2 Unknown 200 enrolled Jun Li
RandomizedParallel-groupOpen-labelTreatment

Summary

To elucidate the efficacy and safety of weixin decoction in the treatment of heart failure after myocardial infarction.

Timeline

Start
2020-12-15
Primary completion
2022-06-30
Completion
2023-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Modified Wenxin Decoction Unknown 150 ml —
Subject Modified Wenxin Decoction Unknown 200 ml —